Avid Bioservices, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
Mark Ziebell, VP and General Counsel of Avid Bioservices, reports the disposal of common stock, stock options, restricted stock units, and performance stock units due to the merger with Space Mergerco, Inc.
Director Jeanne Thoma reports the disposal of Avid Bioservices shares, stock options, and restricted stock units due to the merger with Space Mergerco, Inc.
Director Gregory Sargen reports the disposal of common stock, stock options, and restricted stock units due to the merger of Avid Bioservices, Inc. with Space Mergerco, Inc.
Richard A. Richieri, Chief Operations Officer of Avid Bioservices, Inc., reports the disposal of common stock, stock options, restricted stock units, and performance stock units due to the merger with Space Mergerco, Inc.
Director Catherine Mackey reports the disposal of Avid Bioservices shares, stock options, and restricted stock units due to the merger with Space Mergerco, Inc.
Matthew Kwietniak, Chief Commercial Officer of Avid Bioservices, reports the disposal of common stock, restricted stock units (RSUs), and performance stock units (PSUs) due to the merger with Space Mergerco, Inc., resulting in a cash payment of $12.50 per share.
Daniel Hart, CFO of Avid Bioservices, Inc., disposed of common stock, stock options, restricted stock units, and performance stock units due to the merger with Space Mergerco, Inc., receiving cash payments as per the merger agreement.
Director Richard B. Hancock reports the disposal of common stock, stock options, and restricted stock units due to the merger of Avid Bioservices, Inc. with Space Mergerco, Inc.
Form 4: Avid Bioservices CEO Nicholas Green Disposes of Shares, Options, and Stock Units Following Merger
Following the merger of Space Mergerco, Inc. with Avid Bioservices, Inc., CEO Nicholas Green disposed of his shares, options, restricted stock units (RSUs), and performance stock units (PSUs) for a cash payment of $12.50 per share.
Director Joseph Carleone reports the disposal of common stock, stock options, and restricted stock units due to the merger of Avid Bioservices, Inc. with Space Mergerco, Inc.
Director Esther M. Alegria reports the disposal of common stock, stock options, and restricted stock units due to the merger of Avid Bioservices, Inc. with Space Mergerco, Inc.
Director Richard B. Hancock of Avid Bioservices, Inc. reported a gift of 20,128 common shares on January 27, 2025.
Avid Bioservices' Chief Operations Officer, Richard Richieri, reported the acquisition and disposal of company stock and restricted stock units, including sales to cover tax obligations.
Form 4: Avid Bioservices Executive Richard A. Richieri Acquires Shares Through Employee Stock Purchase Plan
Chief Operations Officer of Avid Bioservices, Richard A. Richieri, acquired shares of common stock through the company's Employee Stock Purchase Plan.
Avid Bioservices' Chief Financial Officer, Daniel R. Hart, acquired 1,755 shares of common stock through the company's Employee Stock Purchase Plan at a price of $6.052 per share.
Avid Bioservices CEO Nicholas Green acquired 1,755 shares of common stock through the company's Employee Stock Purchase Plan at a price of $6.052 per share.
Avid Bioservices' Chief Operations Officer, Richard A. Richieri, accelerated the vesting of performance stock units and sold shares to cover tax obligations in connection with the company's pending acquisition.
Avid Bioservices' Chief Commercial Officer, Matthew R. Kwietniak, accelerated the vesting of equity awards and sold shares to cover tax obligations in connection with the company's acquisition by GHO Capital Partners LLP and Ampersand Capital Partners.
Avid Bioservices' Chief Financial Officer, Daniel R. Hart, engaged in multiple stock transactions, including the vesting and sale of shares, following the acceleration of equity awards due to a pending merger.
Avid Bioservices CEO Nicholas Green accelerated the vesting of equity awards and sold shares to cover tax obligations in connection with the company's merger agreement.
Avid Bioservices CEO Nicholas Green sold a total of 226,653 shares of common stock in multiple transactions between December 20th and December 24th, 2024.
Director Jeanne Thoma of Avid Bioservices, Inc. reports the vesting and acquisition of restricted stock units on December 14, 2024.
Director Gregory Sargen of Avid Bioservices, Inc. reports the vesting and acquisition of restricted stock units.
Director Catherine Mackey of Avid Bioservices, Inc. reports the vesting of restricted stock units and a new equity award grant.
Richard B. Hancock, a director at Avid Bioservices, Inc., reported the vesting of restricted stock units and a new equity award grant.
Director Joseph Carleone of Avid Bioservices, Inc. reports the vesting of restricted stock units and a new equity award grant.
Form 4: Avid Bioservices Director Exercises and Acquires Shares Through Vesting of Restricted Stock Units
Director Esther M. Alegria exercised and acquired shares of Avid Bioservices stock through the vesting of restricted stock units on December 14, 2024.
Chief Commercial Officer Matthew Kwietniak of Avid Bioservices reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Richard A. Richieri, Chief Operations Officer of Avid Bioservices, Inc., reports the acquisition and disposal of common stock and restricted stock units, including sales to cover tax obligations.
Matthew Kwietniak, Chief Commercial Officer of Avid Bioservices, reports the acquisition and disposal of common stock and restricted stock units.